Gossamer Bio (NASDAQ:GOSS) Price Target Raised to $10.00 : c

Gossamer Bio (NASDAQ:GOSS – Free Report) had its target price increased by HC Wainwright from $5.00 to $10.00 in a report published on Monday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Gossamer Bio’s Q4 2023 earnings at ($0.17) EPS, FY2023 earnings at ($1.12) EPS, […]

Related Keywords

United States , Bryan Giraudo , Gossamer Bio Company Profile , Principal Financial Group Inc , Securities Exchange Commission , Acadian Asset Management , Gossamer Bio Inc , Vanguard Personalized Indexing Management , Td Asset Management Inc , Topco Ltd , Gossamer Bio , Free Report , Bio Trading Down , Get Free Report , Exchange Commission , Financial Group , Management Inc , Asset Management , Tyrosine Kinase , Gossamer Bio Daily , Nasdaq Goss , Goss , Medical , Boost Price Target , Hc Wainwright ,